The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(1-(3-(6-(pyrrolidin-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl)benzoyl)piperidin-4-yl)benzonitrile ID: ALA2322372
PubChem CID: 68288944
Max Phase: Preclinical
Molecular Formula: C29H28N6O
Molecular Weight: 476.58
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(C2CCN(C(=O)c3cccc(-c4nc5cc(N6CCCC6)ncc5[nH]4)c3)CC2)cc1
Standard InChI: InChI=1S/C29H28N6O/c30-18-20-6-8-21(9-7-20)22-10-14-35(15-11-22)29(36)24-5-3-4-23(16-24)28-32-25-17-27(31-19-26(25)33-28)34-12-1-2-13-34/h3-9,16-17,19,22H,1-2,10-15H2,(H,32,33)
Standard InChI Key: GUCACUBJEZUIJZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
2.0228 -9.3326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5046 -8.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0082 -8.1352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8418 -9.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3372 -9.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9826 -7.8991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1327 -6.6631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6374 -6.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4787 -7.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3307 -9.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8258 -8.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4691 -7.5402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6173 -6.3056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1221 -6.4260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.9651 -7.4197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1612 -7.3234 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3532 -7.0124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8490 -7.1253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6946 -5.8864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0445 -4.5346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5536 -4.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7031 -5.6606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 3.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2121 3.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7463 5.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7537 5.2860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2149 3.8587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 3 1 0
6 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 3 0
2 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
30 31 1 0
31 23 1 0
27 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 476.58Molecular Weight (Monoisotopic): 476.2325AlogP: 5.12#Rotatable Bonds: 4Polar Surface Area: 88.91Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.59CX Basic pKa: 6.09CX LogP: 4.60CX LogD: 4.58Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.44Np Likeness Score: -1.65
References 1. Oslob JD, Johnson RJ, Cai H, Feng SQ, Hu L, Kosaka Y, Lai J, Sivaraja M, Tep S, Yang H, Zaharia CA, Evanchik MJ, McDowell RS.. (2013) Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation., 4 (1): [PMID:24900571 ] [10.1021/ml300335r ] 2. (2014) Heterocyclic modulators of lipid synthesis,